2000 Article Archive CD from the International Journal of Pharmaceutical Compounding

Sign On

Volume 4, 2000 Archive
Six back issues from 2000 on one convenient archive.

Permanent storage and easy retrieval of IJPC articles and formulations.

Print journal articles in color from the PDF file for your marketing needs.
Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.

Only $200.00

(Select Format)

This archive contains the following articles listed by volume, issue and page number:


Issues Included
Volume/Issue	Date	Title
Vol. 4 No. 1	January/February 2000	Compounding for Pain Management
Vol. 4 No. 2	March/April 2000	Compounding for Diabetes Patients
Vol. 4 No. 3	May/June 2000	Compounding for the Ear, Nose and Throat
Vol. 4 No. 4	July/August 2000	Compounding for Hospice and Cancer Patients
Vol. 4 No. 5	September/October 2000	Compounding for Immune System Disorders
Vol. 4 No .6	November/December 2000	Compounding for Hormone Replacement Therapy

Volume 4, 2000 Articles

Title (Click for Details)	Vol/Issue	Page

Volume 4, 2000 Articles
Chronic Neuropathic Pain: Pharmacological Interventions in New Millennium	Vol. 4 No. 1	6
The Psychology of Pain	Vol. 4 No. 1	12
Opioids: A Review of the Pharmacology	Vol. 4 No. 1	17
Fibromyalgia	Vol. 4 No. 1	21
Compounding Intrathecal Medications	Vol. 4 No. 1	24
Book Review: The NMDA Receptor	Vol. 4 No. 1	26
Postherpetic Neuralgia	Vol. 4 No. 1	27
Compounding Software: An Evaluation	Vol. 4 No. 1	32
Marketing Your Prescription Compounding Practice: Part One	Vol. 4 No. 1	36
Marketing Tip: Marketing Reps Can Help	Vol. 4 No. 1	39
Profile of a Practice	Vol. 4 No. 1	40
Particulates in Parenterals	Vol. 4 No. 1	43
The Basics of Compounding: Compounding Medication Sticks	Vol. 4 No. 1	44
Clear-Stick Base	Vol. 4 No. 1	45
Styptic Pencil	Vol. 4 No. 1	45
Styptic Pencil (Crayon Type)	Vol. 4 No. 1	45
Analgesic Medication Stick	Vol. 4 No. 1	45
Amitriptyline HCl 2% and Baclofen 2% in PLO	Vol. 4 No. 1	50
Capsaicin 0.075%, Ketamine HCl 2% and Ketoprofen 10% in PLO	Vol. 4 No. 1	51
Capsicum 0.32%, Methyl Salicylate 25% and Menthol 10% Analgesic Cream	Vol. 4 No. 1	52
Clonidine HCl 1-mg/g in VanPen Cream	Vol. 4 No. 1	53
Cyclobenzaprine 1% and Guaifenesin 10% in Speed Gel	Vol. 4 No. 1	54
Dyclonine HCl 1-mg and Diphenhydramine HCl 10-mg Anesthetic Troches	Vol. 4 No. 1	55
Fentanyl 50-mcg Chewable Gummy Gels	Vol. 4 No. 1	56
Fentanyl 25-mcg/0.1-mL Nasal Spray	Vol. 4 No. 1	57
Morphine Sulfate 2.5-mg/mL Inhalation Solution	Vol. 4 No. 1	58
Shingles Ointment/Cream	Vol. 4 No. 1	59
Stiffening Agents, Featured Excipient:	Vol. 4 No. 1	60
Calculations	Vol. 4 No. 1	63
Calibration of Hot Plates	Vol. 4 No. 1	65
Stability of Alatrofloxacin Mesylate in 5% Dextrose Injection and 0.45% Sodium-Chloride Injection	Vol. 4 No. 1	66
Naratriptan HCl in Extemporaneously Compounded Oral Suspensions	Vol. 4 No. 1	69
Physicochemical Stability of Compounded Creams Containing alpha-Hydroxy Acids	Vol. 4 No. 1	72
The Clinical Pharmacist's Role in Compounding for the Diabetic Patient	Vol. 4 No. 2	84
Sugar Substitutes	Vol. 4 No. 2	86
Complications of Diabetes	Vol. 4 No. 2	88
Transdermal Gels in the Treatment of Diabetic Neuropathy	Vol. 4 No. 2	91
L-Arginine and Ascorbic Acid for Diabetic Foot Ulcers	Vol. 4 No. 2	94
Natural-Product Therapies for Treating Diabetic Neuropathy	Vol. 4 No. 2	98
Patient Handout: Diabetes Management Guidelines	Vol. 4 No. 2	100
Complementary Medicine - A Wellness Plan for People with Diabetes	Vol. 4 No. 2	101
Diabetes Book Reviews	Vol. 4 No. 2	103
Analytical Testing of Extemporaneously Compounded Preparations	Vol. 4 No. 2	105
Natural Estrogens: A Review of the Primary Literature	Vol. 4 No. 2	110
Marketing Your Prescription Compounding Practice: Part Two	Vol. 4 No. 2	115
Profile of a Practice	Vol. 4 No. 2	120
Basics of Compounding: Compounding Solutions	Vol. 4 No. 2	122
Chlorhexidine 0.2% Oral Rinse	Vol. 4 No. 2	128
Coenzyme Q10 200-mg Chewable Troches	Vol. 4 No. 2	129
Diabetic Foot-Care Ointments	Vol. 4 No. 2	130
Diabetic Skin-Ulcer Cream	Vol. 4 No. 2	131
Ketamine HCl 5% and Amitriptyline HCl 2% in PLO	Vol. 4 No. 2	132
Ketamine HCl 10%, Gabapentin 6%, Baclofen 2%, Amitriptyline HCl 2% and Clonidine HCl 0.1% in PLO	Vol. 4 No. 2	133
Lipoic Acid 200-mg Chewable Troches	Vol. 4 No. 2	134
Nifedipine 160-mg/mL in PLO	Vol. 4 No. 2	135
Sugar-Free Suspension Structured Vehicle, USP	Vol. 4 No. 2	136
Vanadyl Sulfate 10-mg Capsules	Vol. 4 No. 2	137
Official Solvents, Featured Excipient:	Vol. 4 No. 2	139
Standard Operating Procedure for Cleaning Glassware	Vol. 4 No. 2	144
Calculations	Vol. 4 No. 2	145
Some Studies of the Stability of Compounded Cefazolin Ophthalmic Solution	Vol. 4 No. 2	146
Stability of Ranitidine Hydrochloride with Cefazolin Sodium, Cefbuperazone Sodium, Cefoxitin Sodium and Cephalothin Sodium during Simulated Y-Site Administration	Vol. 4 No. 2	150
Effect of Some Antioxidants on the Color Change of White Lotion	Vol. 4 No. 2	154
Compounding Ear, Nose and Throat Preparations	Vol. 4 No. 3	164
Benzocaine Otic Solution	Vol. 4 No. 3	165
General Nasal Solution Vehicle	Vol. 4 No. 3	166
Desmopressin Acetate Nasal Solution 0.033 mg/mL	Vol. 4 No. 3	167
Saline Nasal Mist	Vol. 4 No. 3	167
Atropine Sulfate 0.5% Nasal Solution	Vol. 4 No. 3	167
Xylometazoline 1-mg/mL HCl Nasal Drops	Vol. 4 No. 3	169
Progesterone 20-mg/mL Nasal Solution	Vol. 4 No. 3	169
Scopolamine Hydrobromide 0.4-mg per 0.1-mL Nasal Solution	Vol. 4 No. 3	169
Xylitol in the Prevention of Otitis Media	Vol. 4 No. 3	171
Xylitol 40% Syrup	Vol. 4 No. 3	174
Xylitol Troches	Vol. 4 No. 3	174
Sildenafil 0.2% Otic Drops	Vol. 4 No. 3	175
Xerostomia	Vol. 4 No. 3	176
Pilocarpine Oral Solution	Vol. 4 No. 3	177
Pharmacological Treatment Options for Snoring	Vol. 4 No. 3	179
Compounding OTC Drugs: A Legal Perspective	Vol. 4 No. 3	180
Needleless Infusion Systems	Vol. 4 No. 3	183
Pharmacy Licensure Requirements	Vol. 4 No. 3	184
Wish You Were Here: Oklahoma Frontier Drug Store Museum	Vol. 4 No. 3	188
Three Drug Stability Lives	Vol. 4 No. 3	190
Cellulose Applications for the Pharmaceutical Industry	Vol. 4 No. 3	196
Marketing Your Prescription Compounding Practice: Part Three	Vol. 4 No. 3	199
Profile of a Practice: Surviving the Competition	Vol. 4 No. 3	203
The Future of Compounding: An Industry Perspective	Vol. 4 No. 3	204
Amphotericin B 100-mg Troches	Vol. 4 No. 3	208
Dimethyl Sulfone 16% Nasal Solution	Vol. 4 No. 3	209
Miconazole 2% Otic Powder	Vol. 4 No. 3	210
Misoprostol 0.001% and Lidocaine 0.5% Oral Rinse	Vol. 4 No. 3	211
Misoprostol 0.0027% Mucoadhesive Powder	Vol. 4 No. 3	212
Mupirocin 1% Nasal Drops	Vol. 4 No. 3	213
Nystatin 250,000-Unit and/or Tetracaine HCl 0.025% Popsicles	Vol. 4 No. 3	214
Saliva Substitute for Dry Mouth/Throat	Vol. 4 No. 3	215
Stomatitis Preparations	Vol. 4 No. 3	216
Tonicity-Adjusting Agents, Featured Excipient:	Vol. 4 No. 3	218
Calculations	Vol. 4 No. 3	221
Assignment of Beyond-Use Dates	Vol. 4 No. 3	222
Dry Heat Sterilization of Parenteral Oil Vehicles	Vol. 4 No. 3	223
Stability of Morphine-Ketamine Mixtures in 0.9% Sodium Chloride Injection Packaged in Syringes, Plastic Bags and MEDICATION CASSETTEª Reservoirs	Vol. 4 No. 3	225
Simple High-Performance Liquid Chromatographic Method for Simultaneous Determination of Fusidic Acid and Betamethasone Dipropionate in a Cream Formulation	Vol. 4 No. 3	229
Stability of an Oral Liquid Dosage Form of Trovafloxacin Mesylate and Its Quantitation in Tablets Using High-Performance Liquid Chromatography	Vol. 4 No. 3	233
Hospice and the Role of the Compounding Pharmacist	Vol. 4 No. 4	246
Nausea and Vomiting in Hospice Patients	Vol. 4 No. 4	250
Ketamine for Pain in Hospice Patients	Vol. 4 No. 4	253
Custom-Making Medications for the Hospice Patient	Vol. 4 No. 4	255
Body-Wash Formula	Vol. 4 No. 4	255
Rinseless Shampoo	Vol. 4 No. 4	255
Dry Mouth Spray	Vol. 4 No. 4	255
Surviving Cancer - How the Compounding Pharmacist Can Help	Vol. 4 No. 4	257
Compounding Using Hazardous Drugs	Vol. 4 No. 4	261
Providing Positive Outcomes through Compounding for Animal Cancer Patients	Vol. 4 No. 4	264
Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease	Vol. 4 No. 4	276
NADH Capsules	Vol. 4 No. 4	278
Short Communication: Compounding for Implantable Pumps	Vol. 4 No. 4	280
Ambulatory Pumps: Part I of a Three-Part Series - Peristaltic Infusion Devices Review	Vol. 4 No. 4	281
Profile of a Practice	Vol. 4 No. 4	287
Book Reviews	Vol. 4 No. 4	288
Basics of Compounding: Compounding Suppositories: Part I - Theoretical Considerations	Vol. 4 No. 4	289
Dacarbazine 8-mg/mL, Doxorubicin HCl 0.8-mg/mL and Ondansetron 0.64-mg/mL injection	Vol. 4 No. 4	296
Dexamethasone 1.2%, Lorazepam 0.1%, Haloperidol 0.1%, Diphenhydramine HCl 2.4% and Metoclopramide HCl 2.4% in PLO	Vol. 4 No. 4	297
Doxorubicin HCl 0.4-mg/mL, Ondansetron HCl 0.48-mg/mL and Vincristine Sulfate 14-mcg/mL Injection	Vol. 4 No. 4	298
Fentanyl 100-mcg/0.1-mL and Promethazine HCl 12.5-mg/0.1-mL in PLO	Vol. 4 No. 4	299
Fentanyl 35-mcg/mL, Bupivacaine HCl 1-mg/mL and Clonidine HCl 9-mcg/mL Intrathecal Solution	Vol. 4 No. 4	300
Lidocaine HCl 2%, Misoprostol 0.003% and Phenytoin 2.5% Topical Gel for Decubitus Ulcers	Vol. 4 No. 4	301
Misoprostol 0.0024% Mouth Rinse for Oral Ulcerations	Vol. 4 No. 4	302
Morphine Sulfate 20-mg/mL and Clonidine HCl 10-mcg/mL Epidural Injection	Vol. 4 No. 4	303
Nasogastric Tube/Percutaneous Endoscopic Gastrostomy Tube Suspension Formula	Vol. 4 No. 4	304
Ondansetron HCl 8-mg/mL in PLO	Vol. 4 No. 4	305
Capsule and Tablet Diluents, Featured Excipient:	Vol. 4 No. 4	306
Basic Compounding Documentation: The Master Formula Form	Vol. 4 No. 4	313
Calculations	Vol. 4 No. 4	314
Experimenting with a New Emulsifying Agent (Tahini) in Mineral Oil Emulsion	Vol. 4 No. 4	315
Microbiological Stability of a Fentanyl, Bupivacaine and Clonidine Mixture in a 0.9% Sodium Chloride Infusion Stored in Syringes and Reservoirs	Vol. 4 No. 4	318
Stability of 5-Fluorouracil in an Extemporaneously Compounded Ophthalmic Solution	Vol. 4 No. 4	320
Correction	Vol. 4 No. 5	330
Human Immunodeficiency Virus and the Acquired Immune Deficiency Syndrome	Vol. 4 No. 5	334
Clinical Management and Review of Sjogren's Syndrome	Vol. 4 No. 5	338
Sodium Fluoride Gel (0.5% Fluoride)	Vol. 4 No. 5	339
Clotrimazole 10 mg Base A Troche	Vol. 4 No. 5	339
Saliva Substitute	Vol. 4 No. 5	340
Compounding with Beta-1, 3-D-Glucan	Vol. 4 No. 5	342
Psoriasis	Vol. 4 No. 5	346
Probiotics and Their Effect on Leaky Gut Syndrome and Associated Diseases	Vol. 4 No. 5	349
Immune System Disorders: What's new and Interesting in Print and On-Line	Vol. 4 No. 5	351
Transdermal Nifedipine for Wound Healing: Case Reports	Vol. 4 No. 5	356
Wish You Were Here: Marvin Samson Center for the History of Pharmacy, University of the Sciences in Philadelphia	Vol. 4 No. 5	359
Profile of A Practice: Hormone Replacement Therapy in the Heartland	Vol. 4 No. 5	362
Ambulatory Syringe Infusion Devices: A Review - Part 2	Vol. 4 No. 5	364
Basics of Compounding: Compounding Suppositories Part 2	Vol. 4 No. 5	371
Artificial Tears for Dry Eyes	Vol. 4 No. 5	376
Capsicum Oleoresin 0.3% and Ketoprofen 10% in PLO Gel	Vol. 4 No. 5	377
Coal Tar Medication Stick	Vol. 4 No. 5	378
Interferon with 0.1% Nonoxynol-9 Gel	Vol. 4 No. 5	379
Interferon Ophthalmic Solution	Vol. 4 No. 5	380
Pilocarpine HCl 2-mg Troches	Vol. 4 No. 5	381
Psoriasis Nail Treatment	Vol. 4 No. 5	382
Psoriasis Ointment, Heavy Moisturizing	Vol. 4 No. 5	383
Sunscreen Gel-Alcoholic, SPF-15	Vol. 4 No. 5	384
Sunscreen Lotion, SPF-40	Vol. 4 No. 5	385
Providing Care for Diabetic Veterinary Patients	Vol. 4 No. 5	386
Capsule and Tablet Lubricants, Featured Excipient:	Vol. 4 No. 5	390
Calculations	Vol. 4 No. 5	393
Basic Compounding Documentation: The Batch Control Sheet	Vol. 4 No. 5	395
Stability of Hydrocortisone Sodium Succinate After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use	Vol. 4 No. 5	396
Stability of Lisinopril Syrup (2 mg/mL) Extemporaneously Compounded from Tablets	Vol. 4 No. 5	398
Pharmaceutical Profile of Vitamin C Tablets and Capsules	Vol. 4 No. 5	400
"Natural" Isomolecular Hormone Replacement: An Evidence-Based Medicine Approach	Vol. 4 No .6	414
Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens-Part 1	Vol. 4 No .6	421
Book Reviews: Women's Health	Vol. 4 No .6	424
Hormone Replacement Therapy: Selected Recent References	Vol. 4 No .6	426
Testosterone Deficiency in Men: New Treatments for Andropause	Vol. 4 No .6	429
Compounded Testosterone Gels: A Guide for Clinicians and Pharmacists	Vol. 4 No .6	432
Zinc Sulfate Heptahydrate 0.1% Solution	Vol. 4 No .6	440
Managing Zinc Deficiency in an Office Setting	Vol. 4 No .6	440
Disposable Ambulatory Infusion Devices: A Review - Part 3	Vol. 4 No .6	442
On-Line Billing for Custom Compounds: The Third-Party Payor	Vol. 4 No .6	445
Fentanyl Troche Protocol	Vol. 4 No .6	447
Profile of a Practice: Med Specialties Pharmacy	Vol. 4 No .6	448
Wish You Were Here: Donald F. Salvatori California Pharmacy Museum	Vol. 4 No .6	450
Basics of Compounding - Inhalation Preparations	Vol. 4 No .6	452
Albuterol Sulfate 0.5% Inhalant Solution (Preservative Free)	Vol. 4 No .6	455
Flunisolide 0.025% Inhalation Solution (Preservative Free)	Vol. 4 No .6	455
Ipratropium Bromide 0.02% Solution (Preservative Free)	Vol. 4 No .6	455
Terbutaline 0.1% Inhalant Solution (Preservative Free)	Vol. 4 No .6	455
Albuterol-Cromolyn-Betamethasone for Inhalation (Preservative Free)	Vol. 4 No .6	455
Albuterol-Ipratropium for Inhalation (Preservative Free)	Vol. 4 No .6	455
Beclomethasone Dipropionate 0.042% Nasal Solution (Preservative Free)	Vol. 4 No .6	455
Estriol and Estradiol 2.5-mg, Progesterone 50-mg, and Testosterone 1-mg Capsules	Vol. 4 No .6	458
Estriol and Estradiol 1.25, 2.5, and 5-mg (BiEst) Capsules	Vol. 4 No .6	459
Estrogen 0.625-mg/5-g Vaginal Gel	Vol. 4 No .6	460
Progesterone Cycle Pack 35/50/75/100-mg Capsules	Vol. 4 No .6	461
Testosterone 1-mg/0.1-mL Nasal Spray	Vol. 4 No .6	462
Testosterone 1-mg/0.1-mL in a PLO Gel	Vol. 4 No .6	463
Testosterone 1-mg/0.1-mL Topical Vaginal/Scrotal Spray	Vol. 4 No .6	464
Triple Estrogen 2.5-mg/0.1-mL PLO	Vol. 4 No .6	465
Triple Estrogen 2.5-mg/0.1-mL Sublingual Drops	Vol. 4 No .6	466
Triple Estrogen 2.5-mg Tablet Triturates	Vol. 4 No .6	467
Estrogen Use in Dogs: Indications and Complications	Vol. 4 No .6	468
Oleaginous Vehicles, Featured Excipient:	Vol. 4 No .6	470
Calculations	Vol. 4 No .6	473
Assignment of a Beyond-Use Date for Compounded Preparations	Vol. 4 No .6	474
Compatibility and Stability of Linezolid Injection Admixed with Gentamicin Sulfate and Tobramycin Sulfate	Vol. 4 No .6	476
Stability of Nafcillin Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use	Vol. 4 No .6	480
Stability of Levothyroxine Sodium Injection in Polypropylene Syringes	Vol. 4 No .6	482

	Mailed CD
	Instant PDF Download